• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur J Med Res . Establishment of a quantitative RT-PCR detection of SARS-CoV-2 virus

tetano

Editor, Senior Moderator
Eur J Med Res


. 2021 Dec 17;26(1):147.
doi: 10.1186/s40001-021-00608-5.
Establishment of a quantitative RT-PCR detection of SARS-CoV-2 virus


Yushen Jiang[SUP] 1 [/SUP], Shanming Zhang[SUP] 2 [/SUP], Hong Qin[SUP] 2 [/SUP], Shuai Meng[SUP] 3 [/SUP], Xuyi Deng[SUP] 4 [/SUP], He Lin[SUP] 5 [/SUP], Xiaoliang Xin[SUP] 3 [/SUP], Yuxin Liang[SUP] 3 [/SUP], Bowen Chen[SUP] 3 [/SUP], Yan Cui[SUP] 3 [/SUP], YiHeng Su[SUP] 3 [/SUP], Pei Liang[SUP] 3 [/SUP], GuangZhi Zhou[SUP] 6 [/SUP], Hongbo Hu[SUP] 6 [/SUP]



Affiliations

Abstract

Background: The outbreak of novel coronavirus disease 2019 (COVID-19) has become a public health emergency of international concern. Quantitative testing of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) virus is demanded in evaluating the efficacy of antiviral drugs and vaccines and RT-PCR can be widely deployed in the clinical assay of viral loads. Here, we developed a quantitative RT-PCR method for SARS-CoV-2 virus detection in this study.
Methods: RT-PCR kits targeting E (envelope) gene, N (nucleocapsid) gene and RdRP (RNA-dependent RNA polymerase) gene of SARS-CoV-2 from Roche Diagnostics were evaluated and E gene kit was employed for quantitative detection of COVID-19 virus using Cobas Z480. Viral load was calculated according to the standard curve established by series dilution of an E-gene RNA standard provided by Tib-Molbiol (a division of Roche Diagnostics). Assay performance was evaluated.
Results: The performance of the assay is acceptable with limit of detection (LOD) below 10E1 copies/μL and lower limit of quantification (LLOQ) as 10E2 copies/μL.
Conclusion: A quantitative detection of the COVID-19 virus based on RT-PCR was established.

Keywords: COVID-19; Quantitative; RNA; RT-PCR; SARS-CoV-2 virus.
 
Back
Top Bottom